Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Radiology

Can I Have Multiple Fibroadenomas in Both Breasts?

At a Glance

Multiple fibroadenomas may occur in one or both breasts, especially in younger women, and having more than one does not by itself increase breast cancer risk. Doctors assess each lump and recommend imaging, biopsy, or monitoring based on its features and changes.

Yes, it is entirely possible to have more than one fibroadenoma, and they can occur in one or both breasts at the same time [1][2]. Having multiple or bilateral (in both breasts) fibroadenomas is a known and relatively common presentation, especially in younger women [1][2]. Discovering multiple lumps can be frightening, but having more than one fibroadenoma does not automatically mean you have breast cancer, nor does it require multiple surgeries [3][4]. Your care team will focus on evaluating each lump to ensure they are benign (non-cancerous), but this does not necessarily mean every single lump will need a biopsy.

How Common Are Multiple Fibroadenomas?

While most women with an ultrasound-diagnosed fibroadenoma have a single lump, many have more than one [5]. In a large screening study of young women with fibroadenomas, nearly one-third had multiple lesions [5]. Research involving adolescents found that about 10% of teenagers with fibroadenomas had them in both breasts [6].

Does Having Multiple Fibroadenomas Increase My Cancer Risk?

Having multiple or bilateral fibroadenomas does not independently increase your breast cancer risk [4]. Breast cancer arising directly from a fibroadenoma is extremely rare [7][2]. Furthermore, having multiple fibroadenomas alone is not a reason for genetic testing; a referral to a genetic counselor is usually only recommended if you have a broader personal or strong family history of breast cancer [8].

When assessing your future breast cancer risk, doctors do not simply count your fibroadenomas. Instead, they look at the microscopic makeup of the tissue (if a biopsy is performed). A complex fibroadenoma is a pathology term for a fibroadenoma containing certain internal tissue changes like cysts. This was previously thought to increase risk, but studies show the risk is actually tied to other associated tissue changes rather than the fibroadenoma itself [9]. The true microscopic factors that matter for your risk profile are:

  • Proliferative disease without atypia (an overgrowth of normal-looking cells), which causes a small increase in future breast cancer risk [10].
  • Atypia (abnormal-looking cells), which can meaningfully increase your future risk and requires a personalized, individualized screening plan [11].

How Will My Care Change?

Having multiple fibroadenomas mostly changes your care by requiring careful, individualized tracking to ensure no lump is hiding something more serious.

Imaging: Not Every Lump Needs a Biopsy

This does not mean every lump needs a separate biopsy. For young women and adolescents, an ultrasound is usually the first test used to evaluate the lumps; a mammogram may be added depending on your age and the ultrasound findings [12].

If the imaging shows convincingly benign features, your doctor may simply monitor them. A core needle biopsy (using a hollow needle to remove a small tissue sample) is generally reserved for a lump that looks unusual, is growing quickly, or has features suspicious for a different type of tumor like a phyllodes tumor (a rare breast tumor that can sometimes be cancerous) [13][3]. While an MRI is sometimes used for problem-solving or high-risk screening, it is never a substitute for a biopsy; if a lump is highly suspicious on any imaging, a biopsy is still required [14].

Monitoring Over Surgery

Surgery is not automatically required just because you have multiple lumps [13]. If a biopsy is done, the most important factor is concordance—meaning the benign pathology results perfectly match what the doctor expected from the imaging. If you have a concordant, simple fibroadenoma, your doctor will give you a specific follow-up interval (often a short-term ultrasound, or returning to your age-appropriate routine screening) [15][16].

Surgical removal is usually only recommended if:

  • A lump grows substantially (though there is no universal size or growth cutoff for surgery) [16].
  • A biopsy shows abnormal cells (atypia) or doctors cannot rule out a phyllodes tumor [3][17].
  • A biopsy result is discordant (does not match the imaging).
  • A lump becomes painful, excessively large, or causes cosmetic concerns and you prefer to have it removed [16][18].

What to Watch For

You cannot reliably diagnose a fibroadenoma just by feeling it. If you have multiple fibroadenomas, your main role is to keep your follow-up appointments and stay aware of meaningful changes in your breasts, without obsessively checking them.

Contact your doctor promptly for an outpatient assessment if you notice:

  • A completely new lump or a new lump under your arm.
  • One of your existing lumps starts growing rapidly or feels distinctly different from the others.
  • Red flag symptoms like persistent skin dimpling or thickening, nipple retraction (pulling inward), or bloody nipple discharge.

If one lump changes, it needs its own reassessment, even if prior biopsies on your other lumps were perfectly benign [19][20].

Common questions in this guide

Can fibroadenomas develop in both breasts?
Yes. A person can have multiple fibroadenomas in one breast or in both breasts, and this pattern is seen particularly often in younger women. Having several lumps does not automatically mean breast cancer.
Do multiple fibroadenomas raise my breast cancer risk?
Multiple or bilateral fibroadenomas alone do not independently increase breast cancer risk, and cancer arising directly in a fibroadenoma is extremely rare. A biopsy may show other changes, such as atypia, meaning abnormal-looking cells, or an overgrowth of cells that can affect future risk and screening recommendations.
Does every breast lump need its own biopsy?
No. In younger patients, ultrasound is often the first test, and a lump with convincingly benign features may be monitored rather than biopsied. A core needle biopsy is more likely when a lump is unusual, growing quickly, or suspicious, or when imaging and an earlier benign result do not match.
When should a fibroadenoma be surgically removed?
Removal may be considered if a lump grows substantially, causes pain or significant cosmetic concern, contains abnormal cells, or cannot be distinguished from a phyllodes tumor. Surgery may also be recommended when biopsy results do not match the imaging; there is no single size or growth cutoff that applies to everyone.
What changes in a breast lump need prompt medical review?
Arrange an assessment for a new lump, a lump that grows rapidly or feels different, or a new lump under the arm. Persistent skin dimpling or thickening, a nipple that pulls inward, or bloody nipple discharge also warrant prompt review. A changing lump should be reassessed even if other lumps have already been shown to be benign.
Do multiple fibroadenomas mean I need genetic testing?
Not by themselves. Genetic counseling is generally considered when there is a strong personal or family history of breast cancer or other features that suggest inherited risk. Your clinician can review your history and decide whether testing is appropriate.

Get notified when new evidence is published on breast fibroadenoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    Circumareolar Incision-subdermal Tunneling Dissection for Excision of Multiple Breast Fibroadenomata.

    Agodirin SO, Rahman GA, Olatoke SA, Akande HJ

    Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society 2017; (23(1)):63-66 doi:10.4103/1117-6806.205749.

    PMID: 28584515
  2. 2

    Bilateral Breast Fibroadenoma With Bilateral Ductal Carcinoma In Situ: A Case Report.

    Wang S, Zhang X, Tian W

    Clinical case reports 2026; (14(1)):e71794 doi:10.1002/ccr3.71794.

    PMID: 41503597
  3. 3

    Enlarging biopsy-proven fibroadenoma: Is surgical excision necessary?

    Dialani V, Chansakul T, Lai KC, et al.

    Clinical imaging 2019; (57()):35-39 doi:10.1016/j.clinimag.2019.03.014.

    PMID: 31103907
  4. 4

    Breast biopsies and breast cancer risk in Israeli BRCA germline pathogenic variant carriers.

    Madorsky Feldman D, Sklair-Levy M, Laitman Y, et al.

    Breast cancer research and treatment 2025; (213(3)):377-384 doi:10.1007/s10549-025-07787-3.

    PMID: 40694193
  5. 5

    Prevalence of breast fibroadenoma in healthy physical examination population in Guangdong province of China: a cross-sectional study.

    Zhu L, Zeng X, Jiang S, et al.

    BMJ open 2022; (12(6)):e057080 doi:10.1136/bmjopen-2021-057080.

    PMID: 35760543
  6. 6

    Main Traits of Breast Fibroadenoma Among Adolescent Girls.

    Sun C, Zhang W, Ma H, et al.

    Cancer biotherapy & radiopharmaceuticals 2020; (35(4)):271-276 doi:10.1089/cbr.2019.3209.

    PMID: 32267738
  7. 7

    Low-Grade Ductal Carcinoma in situ Within a Fibroadenoma of the Breast: A Rare Case Report and Review of the Literature.

    Ni XH, An R, Shi QW, Wang CL

    OncoTargets and therapy 2023; (16()):399-406 doi:10.2147/OTT.S413223.

    PMID: 37325202
  8. 8

    Early onset, multiple, bilateral fibroadenomas of the breast: a case report.

    Im CJ, Miller A, Balassanian R, Mukhtar RA

    BMC women's health 2021; (21(1)):170 doi:10.1186/s12905-021-01311-7.

    PMID: 33882939
  9. 9

    Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study.

    Nassar A, Visscher DW, Degnim AC, et al.

    Breast cancer research and treatment 2015; (153(2)):397-405 doi:10.1007/s10549-015-3535-8.

    PMID: 26264469
  10. 10

    Subtypes of Benign Breast Disease as a Risk Factor of Breast Cancer: A Systematic Review and Meta Analyses.

    Salamat F, Niakan B, Keshtkar A, et al.

    Iranian journal of medical sciences 2018; (43(4)):355-364.

    PMID: 30046203
  11. 11

    Breast cancer risk associated with benign breast disease: systematic review and meta-analysis.

    Dyrstad SW, Yan Y, Fowler AM, Colditz GA

    Breast cancer research and treatment 2015; (149(3)):569-75 doi:10.1007/s10549-014-3254-6.

    PMID: 25636589
  12. 12

    A Comprehensive Review of Breast Fibroadenoma: Correlating Clinical and Pathological Findings.

    Ramala SR, Chandak S, Chandak MS, Annareddy S

    Cureus 2023; (15(12)):e49948 doi:10.7759/cureus.49948.

    PMID: 38179396
  13. 13

    Trends, Outcomes, and Costs of Surgical Excisional Biopsy for Fibroadenoma of the Breast.

    Rath P, Vasigh M, Soleimani T, Euhus DM

    World journal of surgery 2025; (49(4)):797-803 doi:10.1002/wjs.12542.

    PMID: 40059293
  14. 14

    Magnetic resonance imaging of fibroadenoma-like lesions and correlation with Breast Imaging-Reporting and Data System and Kaiser scoring system.

    Cloete DJ, Minne C, Schoub PK, Becker JHR

    SA journal of radiology 2018; (22(2)):1532 doi:10.4102/sajr.v22i2.1532.

    PMID: 31754520
  15. 15

    Six-Month Short-Interval Imaging Follow-Up for Benign Concordant Core Needle Biopsy of the Breast: Outcomes in 1444 Cases With Long-Term Follow-Up.

    Monticciolo DL, Hajdik RL, Hicks MG, et al.

    AJR. American journal of roentgenology 2016; (207(4)):912-917 doi:10.2214/AJR.15.15853.

    PMID: 27340732
  16. 16

    American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions.

    Rosenberger LH, White RL, Tafra L, et al.

    JAMA surgery 2025; (160(12)):1378-1385 doi:10.1001/jamasurg.2025.4392.

    PMID: 41123921
  17. 17

    Biopsy-excision concordance in fibroepithelial breast lesions: Predictors of phyllodes tumor.

    Shimoni I, Mann S, Najjar A, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2026; (52(12)):112180 doi:10.1016/j.ejso.2026.112180.

    PMID: 42822215
  18. 18

    Recurrent bilateral giant breast fibroadenomas with a somatic PIK3CA p.G106V mutation: case report and review of current evidence.

    Zhang Y, Tan Q, Xiao Y, et al.

    BMC women's health 2025; (25(1)):500 doi:10.1186/s12905-025-04032-3.

    PMID: 41121210
  19. 19

    Preoperational diagnosis and management of breast ductal carcinoma in situ arising within fibroadenoma: Two case reports.

    Wu J, Sun KW, Mo QP, et al.

    World journal of clinical cases 2022; (10(11)):3496-3504 doi:10.12998/wjcc.v10.i11.3496.

    PMID: 35611194
  20. 20

    Ductal carcinoma in situ and invasive carcinoma originating in a Fibroadenoma with concurrent benign phyllodes tumor: A case report.

    Ahmad A, Najeeb E, Ul Haq MB, et al.

    International journal of surgery case reports 2024; (116()):109196 doi:10.1016/j.ijscr.2023.109196.

    PMID: 38368667

This page is for informational purposes only and does not constitute medical advice. Your clinician should interpret each lump’s imaging or biopsy results and recommend the appropriate follow-up.